In March 2011 Breakthrough will host its first international conference on Triple Negative Breast Cancer.
This meeting will highlight novel laboratory approaches, innovative pre-clinical science and the latest clinical trial results. The aim is to discuss and advance our understanding of the aetiology, diagnosis and treatment of this challenging disease. The meeting will be a three day programme covering all aspects of triple negative disease with invited plenary speakers and proffered abstracts presented as short talks or posters. We aim to create a workshop atmosphere with ample opportunity for discussion and sharing expertise across disciplines. The meeting which will take place at the Royal Society in